[1] 胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3):209-220. [2] ZHANG W, ZHOU Y W, BAI B, et al. Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography:the Northern Shanghai Study[J]. Clin Interv Aging, 2019, 14:549-556. [3] 由淑萍, 从美丽, 倪国华, 等. 哈萨克族原发性高血压病患者全血DNA甲基化位点筛查及异常甲基化谱的构建[J]. 中国全科医学, 2017, 20(6):678-683. [4] FUNKE-KAISER H, REICHENBERGER F, K-PKE K, et al. Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation[J]. Hum Mol Genet, 2003, 12(4):423-433. [5] FUNKE-KAISER H, THOMAS A, BREMER J, et al. Regulation of the major isoform of human endothelin-converting enzyme-1 by a strong housekeeping promoter modulated by polymorphic microsatellites[J]. J Hypertens, 2003, 21(11):2111-2124. [6] MCLEAN B A, PATEL V B, ZHABYEYEV P, et al. PI3Kα pathway inhibition with doxorubicin treatment results in distinct biventricular atrophy and remodeling with right ventricular dysfunction[J]. J Am Heart Assoc, 2019, 8(9):e010961. [7] 朱林强, 周永焯, 谢晓明, 等. 大鼠腹主动脉缩窄术致大鼠慢性心衰的建模与体会[J]. 现代医院, 2015, 15(10):21-24. [8] CARRICK D, HAIG C, MAZNYCZKA A M, et al. Hypertension, microvascular pathology, and prognosis after an acute myocardial infarction[J]. Hypertension, 2018, 72(3):720-730. [9] MCCULLOUGH P A, CHAN C T, WEINHANDL E D, et al. Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease[J]. Am J Kidney Dis, 2016, 68(5S1):S5-S14. [10] OKWUOSA T M, SOLIMAN E Z, LOPEZ F, et al. Left ventricular hypertrophy and cardiovascular disease risk prediction and reclassification in blacks and whites:the Atherosclerosis Risk in Communities Study[J]. Am Heart J, 2015, 169(1):155-161. [11] 汪波, 占贞贞, 曾麒燕. 心肌纤维化的表观遗传调控研究进展[J]. 中国比较医学杂志, 2019, 29(3):92-97. [12] LI Y W, WANG J, SUN L L, et al. lncRNA myocardial infarction-associated transcript (MIAT) contributed to cardiac hypertrophy by regulating TLR4 via miR-93[J]. Eur J Pharmacol, 2018, 818:508-517. [13] TSAI S H, LU G R, XU X, et al. Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy[J]. Cardiovasc Res, 2017, 113(11):1329-1337. [14] 朱晓颖, 崔紫阳, 刘聪辉, 等. NO/ET-1比值及Hcy水平与OSAHS患者认知功能障碍的相关性分析[J]. 中国现代医学杂志, 2019, 29(11):59-63. [15] 聂阳, 丁立, 黄海潮, 等. PI3K/Akt-eNOS信号通路在甘木通总黄酮后处理减轻大鼠心肌缺血再灌注损伤作用[J]. 中国中药杂志, 2018, 43(23):4692-4697. [16] 王茹, 张磊, 李卫萍, 等. 基于PI3K/Akt/eNOS信号通路探讨补阳还五汤对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J]. 中国实验方剂学杂志, 2019, 25(13):22-27. [17] 李贞燕, 陈敏, 戴日蕾, 等. PI3K和Akt在心血管疾病中的作用[J]. 基础医学与临床, 2019, 39(8):1200-1204. [18] 范亮亮, 马立宁, 彭元亮, 等. PI3K/AKT信号通路与心力衰竭[J]. 生命科学研究, 2015, 19(1):85-90. [19] 叶璐, 郭应坤. 超声心动图评估心肌病研究进展[J]. 中国医学影像技术, 2019, 35(2):298-301. |